respiratory-syncytial-virus

Documents about respiratory-syncytial-virus

• Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus#860388ClinicalTrials.gov
• Estimating cumulative incidence from partially missing time series of respiratory viral infections#928037PLOS
• Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)#877103ClinicalTrials.gov
• Assessing Antiviral Treatments in Early Symptomatic RSV#162526ClinicalTrials.gov
• The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related Hospitalisations in the Australian Capital Territory#830625ClinicalTrials.gov
• Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol#240431PLOS
• "Palivizumab Therapy for RSV-bronchiolitis"#897828ClinicalTrials.gov
• From burden to benefit: overcoming barriers to immunization in adults, with a focus on respiratory syncytial virus.#289157PubMed
• Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection#842546ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine#249663ClinicalTrials.gov
• Safety and Immune Response to an Investigational Vaccine Against Respiratory Syncytial Virus in Healthy Adults#181583ClinicalTrials.gov
• Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)#350024ClinicalTrials.gov
• A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine#651123ClinicalTrials.gov
• Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review#784677Europe PMC
• Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children#847401ClinicalTrials.gov
• A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease#125947ClinicalTrials.gov
• Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study#5093Europe PMC
• Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A) in Healthy Women#268058ClinicalTrials.gov
• A Study of ALS-008176 in Infants Hospitalized With RSV#857350ClinicalTrials.gov
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection#917129ClinicalTrials.gov
• STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)#981266ClinicalTrials.gov
• Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children#217110ClinicalTrials.gov
• Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease#811039ClinicalTrials.gov
• Respiratory syncytial virus sequencing considerations for an expanded Global Influenza Surveillance and Response System#216370WHO IRIS
• A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults#811715ClinicalTrials.gov
• A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections#801715ClinicalTrials.gov
• A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults#398198ClinicalTrials.gov
• Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children#881446ClinicalTrials.gov
• An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants#881591ClinicalTrials.gov
• Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers#967084ClinicalTrials.gov
• A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above#872787ClinicalTrials.gov
• A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)#978847ClinicalTrials.gov
• A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults#261334ClinicalTrials.gov
• Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above#349996ClinicalTrials.gov
• RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults#808012ClinicalTrials.gov
• Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate#829072ClinicalTrials.gov
• Safety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years and Older#146287ClinicalTrials.gov
• Medicinal plants as source of antiviral substances against respiratory syncytial virus#202284GUPEA
• A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults#249677ClinicalTrials.gov
• Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France#893691ClinicalTrials.gov
• Efficacy and Safety of Virus Like Particle Vaccines against Respiratory Syncytial Virus in Mouse and Cotton Rat Models#492314ScholarWorks@GSU
• A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults#146278ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity of a Maternal Respiratory Syncytial Virus (RSV) Vaccine (MKK900) in Healthy Adult Women#806879ClinicalTrials.gov
• RESCEU Study, Defining the Burden of Disease of RSV in Older Adults#826040ClinicalTrials.gov
• Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine#426654ClinicalTrials.gov
• A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older#909915ClinicalTrials.gov
• A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age#895750ClinicalTrials.gov
• Sero-Epidemiological Study of Respiratory Syncytial Virus#757059PhilArchive
• A Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older#146286ClinicalTrials.gov
• Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis#917876ClinicalTrials.gov